Azenta, Inc. (LON:0HQ1)

Market Cap	1.32B +28.6%
Revenue (ttm)	462.63M +4.8%
Net Income	-92.63M
EPS	-2.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	88.81
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6
Open	40.52
Previous Close	40.48
Day's Range	39.85 - 40.96
52-Week Range	16.00 - 46.42
Beta	1.47
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 10, 2026

About Azenta

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sampl...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1978
• Employees: 2,900
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0HQ1

Financial Performance

In fiscal year 2025, Azenta's revenue was $593.82 million, an increase of 3.55% compared to the previous year's $573.45 million. Losses were -$55.76 million, -66.18% less than in 2024.

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 10, 2026

Data Sources Report a data error